SII

The Serum Institute of India, the world’s largest vaccine manufacturer, is expecting to launch another COVID-19 vaccine called Covovax by June, the company’s CEO Adar Poonawalla said on Saturday. The…

Free Fire has a wide variety of in-game cosmetic items like costumes, emotes and . Most of these items can be obtained using diamonds, one of the currencies in the…

Five men died in the fire that bre out in a five-storeyed under-construction building in the SII’s Manjari premises in Pune on Thursday File image of Uddhav Thackeray. @OfficeofUT Pune:…

It is learnt that two million doses each will be sent as commercial supplies to Brazil and Morocco, while a consignment of 1.5 million doses of Covishield will be ivered…

Fire at Serum Institute of India LIVE Updates: Five persons were killed in a blaze that bre out today afternoon at SII plant in Pune’s Manjari area. Maharshtra chief minister…

The Union Health Ministry announced Tuesday all vaccine doses, 1.10 crore from Serum Insititute of India and 55 lakh from Bharat Biotech, will be given to all states and Union…

Doses of the vaccine, Covishield, will initially be shipped to 60 consignee points and will then be distributed to various vaccination centres across India Representational image. PTI New hi: The…

A day before chief ministers’ interaction with Prime Minister Narendra Modi, several states on Sunday said they have made all necessary preparations for the first phase of nationwide roll-out of…

The verbal duel between the chiefs of Bharat Biotech and Serum Institute of India to place after the DCGI announced the approval of the Covaxin and Covishield vaccines Representational image.…

The Serum Institute of India (SII) clarified on Monday that the company is yet to receive the permission from the authority here to export its Covid-19 vaccine to other nations,…

Mumbai: The vaccination drive for the recently approved coronavirus vaccine can start in the country from this month. On Sunday, Drug Controller General of India (DCGI) VG Somani approved Serum…

India’s drugs regulator has given final emergency-use approval for two coronavirus vaccines — Serum Institute of India’s Covishield, developed by Oxford University and pharma major AstraZeneca, and Bharat Biotech’s Covaxin.…

India’s Subject Expert Committee (SEC) in Central Drugs Standard Control Organisation (CDSCO) met on Wednesday to consider coronavirus vaccines for emergency use authorisation (EUA) requested by Pfizer-BioNTech, Bharat Biotech and…

Last month, SII had rejected allegations of serious side-effects made by a participant in the Covishield vaccine trial in Chennai. The man had also sought Rs 5 crore compensation Adar…

The Serum Institute of India (SII) CEO Adar Poonawalla informed that the COVID-19 vaccination in India is likely to start by January 2021. He further said that his company is…

In a major development related to COVID-19 vaccine, Subject Expert Committee (SEC) of Drugs Controller General of India (DCGI) has asked for safety and efficacy data from Serum Institute…

Last week, Prime Minister Narendra Modi had said that a COVID-19 vaccine ‘may be ready in a few weeks’ at an all-party meeting COVAXIN vaccine by Bharath Biotech. New hi: After…

Stressing that the Covishield vaccine is “safe and immunogenic”, the Serum Institute of India (SII) on Tuesday said the incident with the Chennai volunteer was in no way induced by…

A 40-year-old man who to part in the ‘Covishield’ vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and has…

The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two weeks. Adar Poonawalla, Founder and CEO, SII said on Saturday…